Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Tax Provisions (2023 - 2025)

Tg Therapeutics (TGTX) has 2 years of Tax Provisions data on record, last reported at $22.1 million in Q4 2025.

  • For Q4 2025, Tax Provisions rose 944.81% year-over-year to $22.1 million; the TTM value through Dec 2025 reached -$339.8 million, down 15544.95%, while the annual FY2025 figure was -$339.8 million, 15468.11% down from the prior year.
  • Tax Provisions reached $22.1 million in Q4 2025 per TGTX's latest filing, up from -$365.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $22.1 million in Q4 2025 and bottomed at -$365.0 million in Q3 2025.